Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/26 17:55 | 4/2/26 | VYGR | Health | BioPrd | Biological Products, (No Diag | Sandrock Alfred | MA | DO | P,CEO | 4 | S | -184 | 3.72 | 0 | -50 | 510 | D | |||||||||||||||
2/26/26 09:48 | 2/24/26 | VYGR | Health | BioPrd | Biological Products, (No Diag | Swartz Robin | MA | O | COO,CBO | 3 | S | -55 | 3.71 | 0 | -15 | 210 | D | |||||||||||||||
2/26/26 09:46 | 2/24/26 | VYGR | Health | BioPrd | Biological Products, (No Diag | Jorgensen Nathan D. | MA | O | CFO | 1 | S | -18 | 3.77 | 0 | -5 | 151 | D | |||||||||||||||
2/26/26 09:44 | 2/24/26 | VYGR | Health | BioPrd | Biological Products, (No Diag | Carter Todd Alfred | MA | O | Chief Sc | 3 | S | -41 | 3.69 | 0 | -11 | 153 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |